πŸ‡ΊπŸ‡Έ FDA
Patent

US 10640558

Anti-IL-25 antibodies and uses thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 10640558 (Anti-IL-25 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P